Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2007 May 4:4:16.
doi: 10.1186/1742-4682-4-16.

Does the immune reaction cause malignant transformation by disrupting cell-to-cell or cell-to-matrix communications?

Affiliations
Review

Does the immune reaction cause malignant transformation by disrupting cell-to-cell or cell-to-matrix communications?

Richmond T Prehn. Theor Biol Med Model. .

Abstract

TUMOR PROGRESSION: In many (perhaps in all) tumor systems, a malignant cancer is preceded by a benign lesion. Most benign lesions do not transform to malignancy and many regress. The final transformative step to malignancy differs from the preceding steps in, among other things, that it often occurs in the absence of the original carcinogenic stimulus.

Mechanism of immunostimulation: Relatively low titers of specific immune reactants are known to stimulate, but cell-to-cell or cell-to-matrix interactions appear to be major inhibitors of tumor-growth. Therefore, it seems reasonable to hypothesize that the mechanism of immunostimulation may be an interference with cell-to-cell or cell-to-matrix communication by a sub-lethal immune-reaction.

Discussion: While the above hypothesis remains unproven, some evidence suggests that immunity may have a major facilitating effect on tumor growth especially at the time of malignant transformation. There is even some evidence suggesting that transformation in vivo may seldom occur in the absence of immunostimulation of the premalignant lesion. Positive selection by the immune reaction may be the reason that tumors are immunogenic.

PubMed Disclaimer

Figures

Figure 1
Figure 1
The immune response curve (IRC), idealized from data in [10]. The lettered and numbered points are inserted only to aid the discussion.

Similar articles

Cited by

References

    1. Foulds L. The experimental study of tumor progression; a review. Cancer Res. 1954;14:337–339. - PubMed
    1. Prehn RT. Rate-limiting step in the progression of mouse breast tumors. Int J Cancer. 1977;19:670–672. doi: 10.1002/ijc.2910190511. - DOI - PubMed
    1. Lappé MA, Prehn RT. Immunologic surveillance at the macroscopic level: nonselective elimination of premalignant skin papillomas. Cancer Res. 1969;29:2374–2378. - PubMed
    1. Cairns J. Cancer and the immortal strand hypothesis. Genetics. 2006;174:1069–1072. doi: 10.1534/genetics.104.66886. - DOI - PMC - PubMed
    1. Halpern MT, Gillespie BW, Warner KE. Patterns of absolute risk of lung cancer mortality in former smokers. J Natl Cancer Inst. 1993;85:457–464. doi: 10.1093/jnci/85.6.457. - DOI - PubMed

MeSH terms